ARCHIVES

House Members Urge FDA to Review Fast Track Policies

This article is from The Cancer Letter archive.

Vol. 28 No. 27 | July 5, 2002

Download PDF Visit The Full Archive

Related Articles

Retrospective Data Clean-Up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”.

February 15, 2002

New Report On Survival Data Available From NCI

July 25, 1975

Plan To Reprogram $10 Million On Construction Funds Draws Criticism

November 19, 1976

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

July 6, 1990

Von Eschenbach To Leave FDA Jan. 20, Says He Was “In Love” With The Agency.

December 19, 2008

NCI Fund Grants To Increase Minority Internet Access.

October 6, 2000